Fig. 2From: Most-enhancing tumor volume by MRI radiomics predicts recurrence-free survival “early on” in neoadjuvant treatment of breast cancerBoxplots of the most enhancing tumor volume, METV (left), and functional tumor volume, FTV (right) [8] at the pre-treatment and early treatment time points for cases without and with a recurrence, respectively. Here, the line within the box marks the median value, the bottom and top of the box mark the 25th and 75th percentile, respectively, the whiskers mark the extremes not considered outliers, and ‘+’ mark individual outliersBack to article page